文献速递甲状腺疾病

充足碘供应对斯洛文尼亚碘致甲状腺疾病发病率的影响

Effects of Adequate Iodine Supply on the Incidence of Iodine-Induced Thyroid Disorders in Slovenia.
PubMed 文献 · Thyroid · 2017-02-01

该回顾性研究分析了1998至2009年斯洛文尼亚卢布尔雅那大学医学中心甲状腺科885例首次诊断为碘致甲状腺功能亢进症(II-Hyper)或碘致甲状腺功能减退症(II-Hypo)的患者,比较1999年食盐加碘量从10 mg/kg提高至25 mg/kg前后发病率与治疗时长的变化。结果发现加碘量提高后II-Hypo发病率显著升高(p < 0.001),II-Hyper发病率显著降低(p < 0.001),II-Hyper治疗时长显著缩短。

要点

  • 加碘量提高后II-Hypo发病率较前显著升高(p < 0.001),II-Hyper发病率较前显著降低(p < 0.001)。
  • 加碘量提高后II-Hyper中显性甲亢比例下降,亚临床甲亢比例升高(p = 0.007和p = 0.015)。
  • 加碘量提高后抗甲状腺药物与高氯酸盐治疗时长均较前显著缩短(p = 0.001和p = 0.002)。

核心结论

  • 加碘量提高后,II-Hypo发病率较前升高,II-Hyper发病率较前降低。
  • II-Hyper病情较轻、治疗时长较短,以及服用胺碘酮患者无甲状腺疾病期较长,是建立充足碘供应后的额外有益临床结果。

研究设计与样本

  • 回顾性研究,回顾1998年至2009年间在卢布尔雅那大学医学中心甲状腺科首次诊断为II-Hyper或II-Hypo的885例斯洛文尼亚患者的医疗记录。
  • II-Hyper和II-Hypo由10名资深内科专科医师中的一位诊断,诊断基于充分的患者病史以及促甲状腺激素、甲状腺激素和甲状腺抗体的实验室检测。
  • 多数病例进行了甲状腺超声和甲状腺闪烁显像检查,同时回顾了人口学特征及治疗类型和时长。

主要发现

  • 加碘量提高后II-Hypo发病率较提高前显著升高(p < 0.001)。
  • 加碘量提高后II-Hyper发病率较提高前显著降低(p < 0.001)。
  • 加碘量提高后显性甲亢患者比例下降,主要因亚临床甲亢患者比例升高(p = 0.007和p = 0.015)。
  • 加碘量提高后抗甲状腺药物和高氯酸盐治疗时长均较提高前显著缩短(p = 0.001和p = 0.002)。
  • 过量碘摄入(EII)所致甲状腺疾病的发生年份与胺碘酮治疗时长呈显著正相关(R = 0.132;p = 0.048),提示患者充足碘供应时间越长,发生EII所致甲状腺疾病前可服用胺碘酮的时间越长。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study aimed to establish the changes in the incidence and characteristics of iodine-induced hyperthyroidism (II-Hyper) and iodine-induced hypothyroidism (II-Hypo) in the two-year period before and the 10-year period after the increase in mandatory salt iodization from the previous 10 mg/kg of potassium iodide to 25 mg/kg in 1999. Furthermore, the aim was to determine the duration of treatment in II-Hyper patients, since no data regarding severity and treatment of II-Hyper with respect to iodine supply are available. METHODS: This retrospective study reviewed medical records of 885 Slovenian patients first diagnosed with II-Hyper or II-Hypo between 1998 and 2009 at the Thyroid Department of the University Medical Centre Ljubljana. II-Hyper and II-Hypo were diagnosed by one out of 10 senior internal medicine specialists. The diagnosis was based on an adequate patient history, and laboratory measurements of thyrotropin, thyroid hormones, and thyroid antibodies. In most cases, thyroid ultrasound and thyroid scintigraphy were performed. Demographic characteristics and the type and the duration of treatment were also reviewed. RESULTS: The incidence of II-Hypo was significantly higher after the increase in iodine supply than it was before (p < 0.001). After the increase in iodine supply, the incidence of II-Hyper was significantly lower than before the increase (p < 0.001). Furthermore, the portion of patients with overt hyperthyroidism decreased, predominantly due to the increased proportion of patients with subclinical hyperthyroidism (p = 0.007 and p = 0.015, respectively). The duration of treatment with antithyroid drugs and perchlorate was significantly shorter after the increase in iodine supply than it was before (p = 0.001 and p = 0.002, respectively). A significantly positive correlation between the year of the occurrence of excessive iodine intake (EII)-induced thyroid disease and the duration of treatment with amiodarone was found (R = 0.132; p = 0.048), suggesting that the longer the patients had an adequate iodine supply, the longer they could take amiodarone before EII-induced thyroid disorder developed. CONCLUSIONS: After the increase in iodine supply, a higher incidence of II-Hypo and a lower incidence of II-Hyper were observed than before the increase. Less severe II-Hyper, shorter duration of treatment of II-Hyper, as well as a longer thyroid disease-free period in patients on amiodarone are additional beneficial clinical consequences after the establishment of an adequate iodine supply.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Bajuk V, Zaletel K, Pirnat E, et al. Effects of Adequate Iodine Supply on the Incidence of Iodine-Induced Thyroid Disorders in Slovenia. Thyroid. 2017. PMID: 28059636. doi:10.1089/thy.2016.0186

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。